On the other hand, MMP-9/MMP-2 protein expression may be downregulated by inhibiting the activation of Smad2/3 (pSmad2/3), thereby inhibiting the occurrence of EMT and weakening the metastatic ability of tumor cells. This evidence concerns the gene SMAD2 and neoplasm.